Drug Shortage Report for CUPRIMINE
Report ID | 186886 |
Drug Identification Number | 00016055 |
Brand name | CUPRIMINE |
Common or Proper name | CUPRIMINE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PENICILLAMINE |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 250 |
ATC code | M01CC |
ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-04-03 |
Actual start date | |
Estimated end date | 2023-04-28 |
Actual end date | 2022-03-21 |
Shortage status | Avoided shortage |
Updated date | 2023-03-23 |
Company comments | Requirements related to complying with GUI-0069 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-03-13 | English | Compare |
v2 | 2023-03-13 | French | Compare |
v3 | 2023-03-23 | English | Compare |
Showing 1 to 3 of 3